175 related articles for article (PubMed ID: 19778521)
1. Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells.
Jung HJ; Park JW; Lee JS; Lee SR; Jang BC; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2009 Dec; 390(1):71-6. PubMed ID: 19778521
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
3. D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells.
Park JY; Park JW; Suh SI; Baek WK
Biochem Biophys Res Commun; 2009 Apr; 382(1):96-101. PubMed ID: 19254699
[TBL] [Abstract][Full Text] [Related]
4. Melatonin down-regulates HIF-1 alpha expression through inhibition of protein translation in prostate cancer cells.
Park JW; Hwang MS; Suh SI; Baek WK
J Pineal Res; 2009 May; 46(4):415-21. PubMed ID: 19552765
[TBL] [Abstract][Full Text] [Related]
5. Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.
Jung HJ; Suh SI; Suh MH; Baek WK; Park JW
Cancer Lett; 2011 Apr; 303(1):39-46. PubMed ID: 21316841
[TBL] [Abstract][Full Text] [Related]
6. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
Rapisarda A; Melillo G
Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
Luo Y; He DL; Ning L; Shen SL; Li L; Li X
Chin Med J (Engl); 2006 May; 119(9):713-8. PubMed ID: 16701010
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
10. Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha.
Lim JH; Park JW; Kim MS; Park SK; Johnson RS; Chun YS
Mol Pharmacol; 2006 Dec; 70(6):1856-65. PubMed ID: 16940187
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
12. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
Zi X; Zhang J; Agarwal R; Pollak M
Cancer Res; 2000 Oct; 60(20):5617-20. PubMed ID: 11059749
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone inhibits HIF-1α expression in a topoisomerase II-independent pathway.
Toh YM; Li TK
Clin Cancer Res; 2011 Aug; 17(15):5026-37. PubMed ID: 21653687
[TBL] [Abstract][Full Text] [Related]
14. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
16. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
Monsef N; Helczynski L; Lundwall A; Påhlman S;
Prostate; 2007 Aug; 67(11):1219-29. PubMed ID: 17562539
[TBL] [Abstract][Full Text] [Related]
17. Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Hasegawa M; Mikami S; Oya M
Prostate; 2010 Feb; 70(2):162-9. PubMed ID: 19760626
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
Thomas R; Kim MH
Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro.
Luo Y; He DL; Ning L; Shen SL; Li L; Li X; Zhau HE; Chung LW
BJU Int; 2006 Dec; 98(6):1315-9. PubMed ID: 16956360
[TBL] [Abstract][Full Text] [Related]
20. [Vector-mediated shRNA inhibits HIF-1alpha expression in prostate cancer cells].
Ping H; Xing NZ; Chen XC; Zhang JH; Yan-Yong ; Yang Y
Zhonghua Nan Ke Xue; 2008 Nov; 14(11):993-7. PubMed ID: 19102499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
